Sen. Hassan, Colleagues Stand Up to Big Pharma on High Prescription Drug Prices
March 19, 2022
March 19, 2022
WASHINGTON, March 19 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
U.S. Senator Maggie Hassan joined her colleagues in pressing the CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) for answers, after PhRMA's inadequate response to the group's questions about two recent analyses revealing troubling, widespread, and rapid price increases for brand name drugs in January 2022. PhRMA's response to the lawmakers' init . . .
U.S. Senator Maggie Hassan joined her colleagues in pressing the CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) for answers, after PhRMA's inadequate response to the group's questions about two recent analyses revealing troubling, widespread, and rapid price increases for brand name drugs in January 2022. PhRMA's response to the lawmakers' init . . .